Clinical Trial Update: Ultra Low Dose Orbital Radiation Therapy in Treating Patients With Stage I-IV Indolent B-cell Lymphoma or Mantle Cell Lymphoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating ultra-low-dose orbital radiation therapy for Stage I-IV indolent B-cell non-Hodgkin lymphoma and mantle cell lymphoma; the study is cur…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Follicular Lymphoma
• Indolent Non-hodgkin Lymphoma
• Malt Lymphoma
• Mantle Cell Lymphoma
• Ocular Adnexal Lymphoma
• Orbital Lymphoma

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Ann Arbor Stage I B-Cell Non-Hodgkin Lymphoma, Ann Arbor Stage I Grade 1 Follicular Lymphoma | Phase 2 | Status: ACTIVE_NOT_RECRUITING